AGEN 8-K 2026-11-05

AGENUS INC (AGEN) 8-K dated 2026-11-05 — accession 0001193125-26-448637.

AGENUS INC (AGEN) is a biotechnology company listed on US.

AGENUS INC filed a 8-K on 2026-11-05. Accession 0001193125-26-448637.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported AGEN revenue for 2025-12-31 was $114.2M. Net income was -$3.1M. Revenue was up 10.4% from 2024-12-31 to 2025-12-31. AGEN currently screens at market cap $134.5M.

Not investment advice. The AGEN SEC hub lists recent forms. The stock page is the research view.